JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




First published online November 13, 2009, 10.2967/jnmt.109.064709
doi:10.2967/jnmt.109.064709
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnmt.109.064709v1
37/4/220    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mallarajapatna, G. J.I.
Right arrow Articles by Ramachandra, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallarajapatna, G. J.I.
Right arrow Articles by Ramachandra, P. G.
Journal of Nuclear Medicine Technology Volume 37, Number 4, 2009 220-222
© 2009 by Society of Nuclear Medicine

PET/CT-Guided Percutaneous Biopsy of Isolated Intramuscular Metastases from Postcricoid Cancer

Govindarajan J.I. Mallarajapatna, Kumar G. Kallur, Nagaraj K. Ramanna, Sridhar P. Susheela and Prashanth G. Ramachandra

Department of Radiology, Bangalore Institute of Oncology and Health Care Global, Bangalore, India

Correspondence: For correspondence or reprints contact: M.J. Govindarajan, No. 6, 3rd cross, LIC colony, Basaveshwar Nagar, Bangalore, 560079 India. E-mail: revathigovind{at}gmail.com

18F-FDG PET/CT has made it possible to identify many unsuspected lesions such as isolated intramuscular metastases because of its ability to detect abnormal metabolic activity in an early stage even without clinical symptoms or morphologic changes. We need to modify our routine techniques for performing biopsies of such lesions because they may not be visualized on morphologic imaging. We describe a technique in which fused PET/CT is used to guide the percutaneous biopsy needle for sampling isolated intramuscular metastatic lesions in a patient whose intramuscular metastases were identified only on PET/CT, not on CT or ultrasound, and were clinically occult.

Key Words: molecular imaging; PET/CT; biopsy; metastases







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2009 by the Society of Nuclear Medicine Technologist Section.